<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Principles of cancer biotherapy</title>
  </titleInfo>
  <titleInfo type="abbreviated">
    <title>Principles of cancer biotherapy</title>
  </titleInfo>
  <name type="personal">
    <namePart>Oldham, Robert K.</namePart>
  </name>
  <name type="personal">
    <namePart>Dillman, Robert O.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">ne</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Dordrecht</placeTerm>
    </place>
    <publisher>Springer</publisher>
    <dateIssued>2009</dateIssued>
    <edition>5th ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <form authority="gmd">electronic resource</form>
    <extent>742 p. : ill. ; 28 cm.</extent>
  </physicalDescription>
  <tableOfContents>Cancer biotherapy : general principles / Robert K. Oldham -- The pathogenesis of cancer metastasis : relevance to therapy / Sun-Jin Kim ... [et al.] -- Developmental therapeutics and the design of clinical trials / Robert K. Oldham -- Recombinant proteins and gnomics in cancer therapy / Kapil Mehta ... [et al.] -- Current concepts in immunology / Robert K. Oldham -- Therapeutic approaches to cancer-associated immune suppression / Robert K. Oldham -- Cancer vaccines / Kenneth A. Foon and Malek M. Safa -- Cytokines / Walter M. Lewko and Robert K. Oldham -- Interferons : therapy for cancer / David Goldstein ... [et al.] -- Monoclonal antibody therapy / Robert O. Dillman -- Immunotoxins / Arthur E. Frankel, Jung-Hee Woo, and David M. Neville -- Drug immunoconjugates / Malek Safa, Kenneth A. Foon, and Robert K. Oldham -- Targeted radionuclide therapy of cancer / John M. Pagel ... [et al.] -- Stem cell/bone marrow transplantation as biotherapy / Robert K. Oldham -- Cellular immunotherapy (CI), where have we been and where are we going? / John R.Yanelli -- Growth and differentiation factors as cancer therapeutics / Kapil Mehta, Robert K. Oldham, and Bulent Ozpolat -- Granulocyte colony-stimulating factor : biology and clinical potential / MaryAnn Foote and George Morstyn -- Granulocyte-macrophage colony-stimulating factor / MaryAnn Foote and George Morstyn -- Cancer gene therapy / Donald J. Buchsbaum ... [et al.] -- Regulatory process for approval of biologicals for cancer therapy / Antonio J. Grillo-López -- Cancer biotherapy : 2009 disease-related activity / Robert K. Oldham and Robert O. Dillman -- Biological therapy of melanoma / Robert K. Oldham -- Biological therapy of genitourinary cancer / Robert K. Oldham -- Biological therapy of colon cancer / Robert O. Dillman -- Biological therapy of breast cancer / Robert O. Dillman -- Biological therapy of lung cancer / Robert O. Dillman -- Biological therapy of B and T cell lymphoproliferative disorders / Robert O. Dillman -- Biological therapy of multiple myeloma / Robert K. Oldham -- Biological therapy of squamous cell cancers of the head and neck / Robert O. Dillman -- Biological therapy of glioblastoma / Robert O. Dillman -- Speculations for 2009 and beyond / Robert K. Oldham.</tableOfContents>
  <note type="statement of responsibility">edited by Robert K. Oldham, Robert O. Dillman.</note>
  <note>Includes bibliographical references and index.</note>
  <note>License restrictions may limit access.</note>
  <subject>
    <topic>Cancer</topic>
    <topic>Immunotherapy</topic>
  </subject>
  <subject>
    <topic>Biological response modifiers</topic>
  </subject>
  <subject>
    <topic>Biological products</topic>
    <topic>Therapeutic use</topic>
  </subject>
  <subject>
    <topic>Antineoplastic Agents</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject>
    <topic>Biological Products</topic>
    <topic>therapeutic use</topic>
  </subject>
  <subject>
    <topic>Immunotherapy</topic>
  </subject>
  <subject>
    <topic>Neoplasms</topic>
    <topic>immunology</topic>
  </subject>
  <subject>
    <topic>Neoplasms</topic>
    <topic>therapy</topic>
  </subject>
  <subject>
    <topic>Biologische Medizin</topic>
  </subject>
  <subject>
    <topic>Krebs (Medizin)</topic>
  </subject>
  <classification authority="lcc">RC271.I45 P75 2009</classification>
  <classification authority="lcc">RC271.I45P75 2009</classification>
  <classification authority="ddc" edition="22">616.994  P R C</classification>
  <classification authority="nlm">2010 F-070</classification>
  <classification authority="nlm">QV 269</classification>
  <classification authority=" "> </classification>
  <relatedItem type="host">
    <titleInfo>
      <title>SpringerLink ebooks - Biomedical and Life Sciences (2009)</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">9789048122776 (hbk. : alk. paper)</identifier>
  <identifier type="isbn">9048122775 (hbk. : alk. paper)</identifier>
  <identifier type="isbn">9789048122899 (eISBN)</identifier>
  <identifier type="isbn">9048122899 (eISBN)</identifier>
  <identifier type="">12607754</identifier>
  <identifier type="uri">http://www.columbia.edu/cgi-bin/cul/resolve?clio7920531</identifier>
  <location>
    <url>http://www.columbia.edu/cgi-bin/cul/resolve?clio7920531</url>
  </location>
  <accessCondition type="restrictionOnAccess">License restrictions may limit access.</accessCondition>
  <recordInfo>
    <recordContentSource authority="marcorg">NLM</recordContentSource>
    <recordCreationDate encoding="marc">120623</recordCreationDate>
    <recordChangeDate encoding="iso8601">20150408114045.0</recordChangeDate>
    <recordIdentifier source="OSt">7920531</recordIdentifier>
  </recordInfo>
</mods>
